EFFECT OF HUMAN SERUM ON FATALITY OF STAPHYLOCOCCAL INFECTION IN MICE

Insights

Human serum enhances staphylococcal infections in mice by activating coagulase. A heat-stable factor in the serum increases mortality, impacting understanding of staphylococcal pathogenesis.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcal coagulase typically does not clot mouse plasma.
  • Understanding factors influencing staphylococcal infection severity is crucial.

Purpose of the Study:

  • To investigate the effect of human serum on staphylococcal infection fatality in mice.
  • To determine if human serum influences staphylococcal coagulase activity in vivo.

Main Methods:

  • Mice were infected with anaerobically grown staphylococci.
  • Some infected mice received human serum, while a control group did not.
  • Plasma clotting activity by staphylococcal coagulase was assessed.

Main Results:

  • Human serum addition activated staphylococcal coagulase to clot mouse plasma.
  • Mice treated with human serum exhibited enhanced mortality compared to controls.
  • A heat-stable factor in human serum was identified as responsible for increased deaths.

Conclusions:

  • Human serum contains factors that potentiate staphylococcal infections in mice.
  • Coagulase activity, influenced by human serum, may play a role in staphylococcal pathogenesis.
  • These findings suggest potential therapeutic targets for staphylococcal infections.

Related Concept Videos